+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Celiac Drug"

Celiac Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Celiac Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 115 Pages
  • Global
From
Global Celiac Diseases Drugs Market 2023-2027 - Product Thumbnail Image

Global Celiac Diseases Drugs Market 2023-2027

  • Report
  • September 2023
  • 155 Pages
  • Global
From
From
Celiac Disease (CD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Celiac Disease (CD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
US Celiac Disease Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Celiac Disease Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
Market Spotlight: Celiac Disease - Product Thumbnail Image

Market Spotlight: Celiac Disease

  • Report
  • March 2021
  • 25 Pages
  • Global
Celiac Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Celiac Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 96 Pages
  • Global
From
Loading Indicator

The Celiac Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for celiac disease. Celiac disease is an autoimmune disorder that affects the digestive system, and is triggered by the ingestion of gluten. Celiac Drugs are designed to reduce the symptoms of the disease, such as abdominal pain, bloating, and diarrhea. These drugs can also help to reduce the risk of long-term complications, such as malnutrition and anemia. Celiac Drugs are typically administered orally, and may include enzyme supplements, probiotics, and other medications. In some cases, a gluten-free diet may be recommended in conjunction with drug therapy. Companies in the Celiac Drug market include AbbVie, Allergan, GlaxoSmithKline, Novartis, and Takeda. Show Less Read more